Infant Bacterial Therapeutics Feed

2026-04-02 09:15:00 Rättelse: Kallelse till årsstämma i Infant Bacterial Therapeutics

2026-04-02 09:15:00 Correction: Notice of Annual General Meeting of Infant Bacterial Therapeutics

2026-03-30 14:30:00 Notice of Annual General Meeting of Infant Bacterial Therapeutics 48,10 SEK | -3,51% | 0,11 MSEK

2026-03-30 14:30:00 Kallelse till årsstämma i Infant Bacterial Therapeutics 48,10 SEK | -3,51% | 0,11 MSEK

2026-03-27 07:30:00 Infant Bacterial Therapeutics AB publicerar Årsredovisning för 2025 49,85 SEK | +2,36% | 0,10 MSEK

2026-03-27 07:30:00 Infant Bacterial Therapeutics AB publishes the Annual Report for 2025 49,85 SEK | +2,36% | 0,10 MSEK

2026-03-03 07:00:00 Infant Bacterial Therapeutics (IBT) publishes results from ”The Connection Study” in Pediatric Research 51,00 SEK | +5,26% | 0,43 MSEK

2026-03-03 07:00:00 Infant Bacterial Therapeutics (IBT) publicerar resultat från “The Connection Study” i Pediatric Research 51,00 SEK | +5,26% | 0,43 MSEK

2026-02-06 07:30:00 Infant Bacterial Therapeutics AB (publ) Bokslutskommuniké 1 januari – 31 december 2025 49,95 SEK | +7,42% | 0,41 MSEK

2026-02-06 07:30:00 Infant Bacterial Therapeutics AB (publ) Year-end-report January 1 – December 31, 2025 49,95 SEK | +7,42% | 0,41 MSEK

2025-12-11 18:05:00 Infant Bacterial Therapeutics secures partnership with BioConnection for production of Drug Product 50,00 SEK | +11,86% | 0,92 MSEK

2025-12-11 18:05:00 Infant Bacterial Therapeutics ingår partnerskap med BioConnection för produktion av läkemedel 50,00 SEK | +11,86% | 0,92 MSEK

2025-11-25 18:41:00 IBT byter väg för marknadsgodkännande för IBP-9414 efter diskussioner med FDA 49,90 SEK | -3,48% | 2,91 MSEK

2025-11-25 18:41:00 IBT changes the IBP-9414 pathway for approval following discussions with the FDA 49,90 SEK | -3,48% | 2,91 MSEK

2025-11-20 16:42:00 Infant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for production of drug substance 57,00 SEK | +22,32% | 1,41 MSEK

2025-11-20 16:42:00 Infant Bacterial Therapeutics AB säkerställer partnerskap med Recipharm Advanced Bio för produktion av läkemedelssubstans 57,00 SEK | +22,32% | 1,41 MSEK

2025-11-13 07:30:00 Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari – 30 september 2025 52,00 SEK | -11,26% | 2,61 MSEK

2025-11-13 07:30:00 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2025 52,00 SEK | -11,26% | 2,61 MSEK

2025-10-20 10:35:00 Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2026 61,00 SEK | -3,17% | 0,24 MSEK

2025-10-20 10:35:00 Infant Bacterial Therapeutics AB (publ) meddelar att valberedningen inför årsstämman 2026 bildats 61,00 SEK | -3,17% | 0,24 MSEK

2025-10-13 14:35:00 Registration work for IBT's drug candidate IBP-9414 continues in the US and Europe 68,60 SEK | +9,58% | 2,65 MSEK

2025-10-13 14:35:00 Registreringsarbetet av IBT:s läkemedelskandidat IBP-9414 fortgår i USA och i Europa 68,60 SEK | +9,58% | 2,65 MSEK

2025-09-10 09:38:00 IBT presented “Avoiding the severe consequences of NEC” at the NEC Society Symposium in Chicago 71,50 SEK | -4,67% | 2,36 MSEK

2025-09-10 09:38:00 IBT presenterade ”Att undvika de allvarliga konsekvenserna av NEC” vid NEC Society Symposium i Chicago 71,50 SEK | -4,67% | 2,36 MSEK

2025-08-20 08:00:00 Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari – 30 juni 2025 52,30 SEK | -1,69% | 0,44 MSEK

2025-08-20 08:00:00 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – June 30, 2025 52,30 SEK | -1,69% | 0,44 MSEK

2025-05-14 07:30:00 Infant Bacterial Therapeutics (IBT) to present results of “The Connection Study” at ESPGHAN 2025 in Helsinki 56,50 SEK | -0,35% | 0,93 MSEK

2025-05-14 07:30:00 Infant Bacterial Therapeutics (IBT) presenterar resultat från ”The Connection Study” vid ESPGHAN 2025 i Helsingfors 56,50 SEK | -0,35% | 0,93 MSEK

2025-05-08 17:45:00 Annual General Meeting of Infant Bacterial Therapeutics 60,60 SEK | -1,78% | 0,29 MSEK

2025-05-08 17:45:00 Årsstämma i Infant Bacterial Therapeutics 60,60 SEK | -1,78% | 0,29 MSEK

2025-05-08 07:00:00 IBT Submits Clinical Study Report for ‘The Connection Study’ to the FDA 61,70 SEK | -0,16% | 1,05 MSEK

2025-05-08 07:00:00 IBT skickar in klinisk studierapport för “The Connection Study” till FDA 61,70 SEK | -0,16% | 1,05 MSEK

2025-05-07 14:30:00 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – March 31, 2025 61,80 SEK | +4,57% | 3,07 MSEK

2025-05-07 14:30:00 Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari – 31 mars 2025 61,80 SEK | +4,57% | 3,07 MSEK

2025-04-24 07:20:00 Infant Bacterial Therapeutics (IBT) to Present Results of “The Connection Study” at PAS 2025 in Honolulu 53,50 SEK | +8,08% | 1,62 MSEK

2025-04-24 07:20:00 Infant Bacterial Therapeutics (IBT) kommer att presentera resultat från ”The Connection Study” vid PAS 2025 i Honolul 53,50 SEK | +8,08% | 1,62 MSEK

2025-04-07 09:40:00 Notice of Annual General Meeting of Infant Bacterial Therapeutics 48,00 SEK | +6,67% | 2,07 MSEK

2025-04-07 09:40:00 Kallelse till årsstämma i Infant Bacterial Therapeutics 48,00 SEK | +6,67% | 2,07 MSEK

2025-03-28 18:52:00 IBT is granted Breakthrough Therapy Designation for its Drug Candidate

2025-03-28 18:52:00 IBT beviljas “Breakthrough Therapy Designation” för sin läkemedelskandidat

2025-03-27 08:00:00 Infant Bacterial Therapeutics AB publicerar Årsredovisning för 2024 36,60 SEK | +7,02% | 1,02 MSEK

2025-03-27 08:00:00 Infant Bacterial Therapeutics AB publishes the Annual Report for 2024 36,60 SEK | +7,02% | 1,02 MSEK

2025-02-13 08:30:00 Infant Bacterial Therapeutics AB (publ) Year-end report January 1 – December 31, 2024 40,10 SEK | -6,09% | 2,69 MSEK

2025-02-13 08:30:00 Infant Bacterial Therapeutics AB (publ) Bokslutskommuniké 1 januari – 31 december 2024 40,10 SEK | -6,09% | 2,69 MSEK

2024-12-20 16:33:00 IBT Continues Development of Drug Candidate IBP-9414 59,00 SEK | +18,00% | 5,15 MSEK

2024-12-20 16:33:00 IBT fortsätter utvecklingen av läkemedelskandidaten IBP-9414 59,00 SEK | +18,00% | 5,15 MSEK

2024-11-14 08:30:00 Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari – 30 september 2024 36,30 SEK | +5,83% | 2,79 MSEK

2024-11-14 08:30:00 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2024 36,30 SEK | +5,83% | 2,79 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Infant Bacterial Therapeutics

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden